Silvant Capital Management »

Ionis Pharmaceuticals shares owned by Silvant Capital Management

Quarter-by-quarter ownership of Ionis Pharmaceuticals (IONS) shares owned by Silvant Capital Management from 13F filings

Historical chart of Silvant Capital Management investment in Ionis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Ionis Pharmaceuticals held by Silvant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ionis Pharmaceuticals by Silvant Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $43k 540 79.29

More positions owned by Silvant Capital Management

NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Microsoft Corporation (MSFT)
Eli Lilly & Co. (LLY)
Apple (AAPL)
Ge Vernova (GEV)
Ge Aerospace Com New (GE)
Meta Platforms Cl A (META)
Royal Caribbean Cruises (RCL)
Visa Com Cl A (V)
Arm Holdings Sponsored Ads (ARM)
Amazon (AMZN)
Teradyne (TER)
Netflix (NFLX)

View all positions for Silvant Capital Management

Top funds holding Ionis Pharmaceuticals

FMR
Capital World Investors
BlackRock
Vanguard Portfolio Management
Wellington Management Company
Vanguard Capital Management
Two Sigma Investments
Royal Bank of Canada
State Street Corporation
Geode Capital Management
T. Rowe Price Associates
Jpmorgan Chase & Co
Artisan Partners Limited Partnership
Tweedy, Browne Company
Deep Track Capital

View all funds holding Ionis Pharmaceuticals